AcelRx Pharmaceuticals, Inc. is a pharmaceutical company focused on the development and commercialization of therapies for the treatment of moderate-to-severe acute pain. The Company operates through the segment, which includes development and commercialization of product candidates for the treatment of pain. Its lead product candidates include ARX-04, Zalviso,...
ACRX - Long
Seems a bit range bound and put in a nice bottom on the long trend line. Blew by the 8EMA and 20SMA and closed over the 50SMA after a blip below 30RSI at the lower part of the range. Big risk trade given the low price and rangy price action. SL set at 1.5xATR which is just below the long-term bottom of the range.
ACRX - 500 Shares
Entry - $2.71
SL -...
Looking at the 1 day chart shows a clear bear flag forming over the past months.
Criteria to enter trade:
Clear break of lower (red) long term support line.
This is an ideal situation to use a Sell Stop Order (where a short order is placed in book at a price below the current market price)
Targets:
Once support is broken looking for a $1.95...
Crazy sell off today. Took a position at 3.40. Considered adding more near the 2.70 lows of the day but couldn't make sense of the price action. Will watch over the next 2 days!
AcelRx Pharmaceuticals, Inc. is a pharmaceutical company focused on the development and commercialization of therapies for the treatment of moderate-to-severe acute pain. The Company operates through the segment, which includes development and commercialization of product candidates for the treatment of pain. Its lead product candidates include ARX-04, Zalviso, which utilize sublingual sufentanil, delivered through a non-invasive route of administration, and ARX-03. ARX-04 is meant for the treatment of moderate-to-severe acute pain to be administered by a healthcare professional to a patient in medically supervised settings. Zalviso is meant for the management of moderate-to-severe acute pain in hospitalized adult patients. ARX-03 provides mild sedation, anxiety reduction and pain relief for patients undergoing painful procedures in a physician's office. It also includes ARX-02, which is meant for the treatment of patients who suffer from breakthrough pain (BTP) due to cancer.
This website uses cookies to ensure you get the best experience on our website. To learn more about cookies, including how to control cookies, please read our Cookies Policy.
ACRX
